Rejuvenate Bio | RoundOS

Weekly digest by email

Loading companies…

Rejuvenate Bio | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Jun 8, 2026	Strategic	$6M	Connecticut Innovations — Role not disclosedDigitalis — Role not disclosedKendall Capital Partners — Role not disclosedMerck Animal Health — Role not disclosedVCapital — Role not disclosed

Investors

Connecticut InnovationsStrategic DigitalisStrategic Kendall Capital PartnersStrategic Merck Animal HealthStrategic VCapitalStrategic

Coverage

Jun 8, 2026Rejuvenate Bio · Strategic

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

TransfyrPhysical AI platform capturing real-world lab science into machine-readable data$25M · Seed

Sources

rejuvenatebio.com ↗